DICE Therapeutics, Inc. (DICE) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 5 recommend buying, 5 recommend holding, and 0 recommend selling.
The analyst consensus price target for DICE is $60.00, representing a +26.2% upside from the current price of $47.55. Price targets range from a low of $60.00 to a high of $60.00.
